文献速递头颈部肿瘤放疗

调强放疗时代鼻咽癌放疗中断对生存的影响:基于大数据智能平台的分析

Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
PubMed 文献 · Radiother Oncol · 2018-11-14

该研究基于大数据智能平台纳入7826例接受调强放疗的鼻咽癌患者,随机分为训练队列和内部验证队列各3913例。递归分割分析确定训练队列中总生存的最佳放疗中断阈值为6.5天,故统一采用7天(<7天 vs ≥7天)分组。结果示放疗中断≥7天在训练队列(5年总生存82.4% vs 86.5%,P=0.001)和验证队列(5年总生存85.2% vs 86.7%,P=0.013)均对总生存有显著不利影响,且为独立不良预后因素(训练队列HR 1.49,95%CI 1.14-1.95,P=0.003;验证队列HR 1.37,95%CI 1.07-1.65,P=0.031)。

要点

  • 训练队列中放疗中断≥7天者5年总生存82.4%,<7天者86.5%(P=0.001)。
  • 验证队列中放疗中断≥7天者5年总生存85.2%,<7天者86.7%(P=0.013)。
  • 放疗中断≥7天是总生存的独立不良预后因素(训练队列HR 1.49,验证队列HR 1.37)。

核心结论

  • 在调强放疗时代,放疗中断独立影响鼻咽癌患者生存,放疗中断≥7天持续不利于鼻咽癌生存。
  • 医疗从业者必须提醒患者尽量减少放疗中断的重要性。

研究设计与样本

  • 基于大数据智能平台识别7826例接受调强放疗的鼻咽癌患者。
  • 采用计算机生成的随机数将患者分配至训练队列(3913例)和内部验证队列(3913例)。
  • 放疗中断定义为实际放疗时间与计划放疗时间之差(假设周一开始)。
  • 采用Kaplan-Meier法进行生存分析,log-rank检验评估差异;采用递归分割分析确定最佳放疗中断阈值;采用Weibull模型进行多因素分析。
  • 主要终点为总生存。

主要发现

  • 训练队列中基于递归分割分析确定的总生存最佳放疗中断阈值为6.5天。
  • 放疗中断≥7天较<7天在训练队列(5年总生存82.4% vs 86.5%;P=0.001)和验证队列(5年总生存85.2% vs 86.7%;P=0.013)均显示显著不利影响。
  • 放疗中断≥7天在训练队列(HR 1.49;95%CI 1.14-1.95;P=0.003)和验证队列(HR 1.37;95%CI 1.07-1.65;P=0.031)均为总生存的独立不良预后因素。
  • 亚组分析显示,无论TNM分期和化疗如何,放疗中断≥7天对接受调强放疗的鼻咽癌患者预后均有显著不良影响(所有P<0.05)。

关键数值与推荐

  • 放疗中断阈值:训练队列递归分割分析得出总生存最佳阈值为6.5天,研究统一采用7天(<7天 vs ≥7天)分组。
  • 训练队列:放疗中断≥7天组5年总生存82.4%,<7天组86.5%(P=0.001)。
  • 验证队列:放疗中断≥7天组5年总生存85.2%,<7天组86.7%(P=0.013)。
  • 训练队列多因素分析:放疗中断≥7天 vs <7天,HR 1.49(95%CI 1.14-1.95;P=0.003)。
  • 验证队列多因素分析:放疗中断≥7天 vs <7天,HR 1.37(95%CI 1.07-1.65;P=0.031)。

临床怎么用

  • 原文结论指出医疗从业者必须提醒患者尽量减少放疗中断的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effect of radiotherapy interruption (RTI) in patients with nasopharyngeal carcinoma (NPC) receiving intensity-modulated radiotherapy (IMRT). PATIENTS AND METHODS: A total of 7826 patients using the well-established big-data intelligence platform were identified. Computer-generated random numbers were used to assign these patients into a training cohort (n = 3913 patients) and an internal validation cohort (n = 3913 patients). RTI was defined as the difference between radiation treatment time and planned radiation time (assuming a Monday start). Survival analysis was performed using the Kaplan-Meier method for survival, and log-rank test to evaluate difference. Optimal RTI threshold was identified using the recursive partitioning analyses (RPAs). Multivariate analysis was performed using the Weibull model. The primary endpoint was overall survival (OS). RESULTS: The optimal threshold of RTI with respect to OS in the training cohort was 6.5 d based on RPAs. Therefore, a uniform threshold of 7 d (<7 vs. ≥7 d) was selected to classify both training and validation cohorts into high and low RTI groups for survival analysis. RTI of ≥7 d showed significant detrimental effects on OS in both training (5-y OS, 82.4% vs 86.5%; P = 0.001) and validation cohorts (5-y OS, 85.2% vs 86.7%; P = 0.013) than those patients with RTI of <7 d. Consistent with results of the univariate analysis, RTI of ≥7 d was found to be an independent unfavorable prognostic factor for OS in both training (HR, 1.49; 95% CI, 1.14-1.95; P = 0.003) and validation cohort (HR, 1.37; 95% CI, 1.07-1.65; P = 0.031). Subgroup analysis showed that RTI of ≥7 d had significant adverse effects on prognosis of NPC patients receiving IMRT, regardless of TNM stage and chemotherapy (P < 0.05 for all). CONCLUSIONS: In the IMRT era, RTI independently influences survival. Raising RTI ≥ 7 d was consistently unfavorable for NPC survival. Medical practitioners must remind patients on the importance of minimizing RT interruptions.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Yao JJ, Zhang F, Gao TS, et al. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis. Radiother Oncol. 2018. PMID: 30448002. doi:10.1016/j.radonc.2018.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。